TB Proof

TB Proof

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • Large numbers of TB survivors in SA struggling with lung damage, experts say

    There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more about this under-recognised problem, Spotlight recently attended a global gathering of experts focused on life after TB.

    ·

  • High hopes for major TB vaccine study recently launched in Paarl

    The world desperately needs an effective TB vaccine to reduce the illness and death still being caused by the centuries’ old bacterium. Chris Bateman visited a study site in Paarl where a promising experimental TB vaccine is now being tested as part of a large multi-country clinical trial.

    ·

  • Massive $200 million TB research programme derailed by US funding cuts

    Just over a month after US President Donald Trump implemented a 90-day freeze of all foreign assistance, the future looks very uncertain for tuberculosis research. Among others, a large TB research programme that was worth up to $200 million was axed last week. Elri Voigt reports.

    ·

  • How tissue donations in KZN are helping to boost our understanding of TB

    Some patients at KwaZulu-Natal hospitals are donating lung tissue for use in TB research. Sue Segar tracks what happens to these tissue samples and explores why these samples are so important to unlocking the mysteries of what the TB bacterium does inside the human body.

    ·

  • 56 000 TB deaths in SA in 2023, according to WHO

    An estimated 56 000 people in South Africa and 1.25 million around the world died of TB in 2023, according to just-published figures from the WHO. This means that in 2023 TB overtook COVID-19 as the top infectious disease killer on the planet. Marcus Low unpacks the new numbers.

    ·

  • Why including pregnant women in a TB study in SA was a big deal

    Pregnant women are typically excluded from clinical trials of new TB medicines. This has led to a lack of solid scientific evidence on how best to treat women who fall ill with TB while they are expecting. Tiyese Jeranji asked local TB experts about the problem and puts the spotlight on a recent study that…

    ·

  • Slow progress after decision to make TB prevention pills more widely available

    Besides preventing illness and death, tuberculosis prevention therapy is estimated to be highly cost effective. Yet, uptake of the medication is not what it could be in South Africa. Tiyese Jeranji asks how much has changed since the Department of Health last year decided to make TB prevention therapy much more widely available.

    ·

  • “Someone had to do it”, says SA TB activist on Time 100 list

    At the age of 19 Phumeza Tisile contracted multidrug-resistant tuberculosis. For four years she battled the disease, losing her hearing in the process. At one stage, a doctor told her to visit a priest and prepare her soul for death. Recently, Tisile (now 33) made it on to TIME magazine’s 2023 TIME100 Next list, as…

    ·